Insulin sensitivity is reflected by characteristic metabolic fingerprints-a fourier transform mass spectrometric non-targeted metabolomics approach

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Lucio, Marianna ^a   Fekete, Agnes ^a   Weigert, Cora ^b,c   Wägele, Brigitte ^a,d   Zhao, Xinjie ^e   Chen, Jing ^e   Fritsche, Andreas ^b,c   Häring, Hans Ulrich ^b,c   Schleicher, Erwin D ^b,c   Xu, Guowang ^d   Schmitt Kopplin, Philippe ^a,d   Lehmann, Rainer ^b,c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; BILE ACID; ESSENTIAL FATTY ACID; FRUCTOSE; GALACTOSE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LINOLEIC ACID; LINOLENIC ACID; LIPID; MANNOSE; PHENYLALANINE; PORPHYRIN; RETINOL; SPHINGOLIPID; STEROID HORMONE; UNSATURATED FATTY ACID;

ADULT; AMINO ACID METABOLISM; ARACHIDONIC ACID METABOLISM; ARTICLE; BILE ACID METABOLISM; BLOOD ANALYSIS; CARBOHYDRATE METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID METABOLISM; FOURIER TRANSFORM MASS SPECTROMETRY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; LIPID METABOLISM; METABOLOMICS; PORPHYRIN METABOLISM; STEROIDOGENESIS; CYCLOTRON; FOURIER ANALYSIS; INSULIN RESISTANCE; PATHOPHYSIOLOGY;

CYCLOTRONS; FOURIER ANALYSIS; HUMANS; INSULIN RESISTANCE; METABOLOMICS; PREDIABETIC STATE;

EID: 78149428043     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013317     Document Type: Article

References (44)

1. DeFronzo RA (2004) Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 88: 787-835.
2. Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. Lancet 365: 1415-1428.
3. Bogdanov M, Matson WR, Wang L, Matson T, Saunders-Pullman R, et al. (2008) Metabolomic profiling to develop blood biomarkers for Parkinson's disease. Brain 131: 389-396.
4. Brindle JT, Antti H, Holmes E, Tranter G, Nicholson JK, et al. (2002) Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med 8: 1439-1444.
5. Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, et al. (2007) Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res 6: 546-551.
6. Lewis GD, Wei R, Liu E, Yang E, Shi X, et al. (2008) Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. J Clin Invest 118: 3503-3512.
7. Kind T, Tolstikov V, Fiehn O, Weiss RH (2007) A comprehensive urinary metabolomic approach for identifying kidney cancer. Anal Biochem 363: 185-195.
8. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, et al. (2009) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457: 910-914.
9. van der GJ, Hankemeier T, McBurney RN (2006) Metabolomics-based systems biology and personalized medicine: moving towards n = 1 clinical trials? Pharmacogenomics 7: 1087-1094.
10. Bain JR, Stevens RD, Wenner BR, Ilkayeva O, Muoio DM, et al. (2009) Metabolomics applied to diabetes research: moving from information to knowledge. Diabetes 58: 2429-2443.
11. Wang C, Kong H, Guan Y, Yang J, Gu J, et al. (2005) Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on highperformance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis. Anal Chem 77: 4108-4116.
12. Yuan K, Kong H, Guan Y, Yang J, Xu G (2007) A GC-based metabonomics investigation of type 2 diabetes by organic acids metabolic profile. J Chromatogr B Analyt Technol Biomed Life Sci 850: 236-240.
13. Salek RM, Maguire ML, Bentley E, Rubtsov DV, Hough T, et al. (2007) A metabolic comparison of urinary changes in type 2 diabetes in mouse, rat and man. Physiol Genomics 29: 99-108.
14. Shaham O, Wei R, Wang TJ, Ricciardi C, Lewis GD, et al. (2008) Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol Syst Biol 4: 214.
15. Makinen VP, Soininen P, Forsblom C, Parkkonen M, Ingman P, et al. (2008) 1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Mol Syst Biol 4: 167.
16. Li X, Xu Z, Lu X, Yang X, Yin P, et al. (2009) Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: Biomarker discovery for diabetes mellitus. Anal Chim Acta 633: 257-262.
17. Zhao X, Peter A, Fritsche J, Elcnerova M, Fritsche A, et al. (2009) Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at? Am J Physiol Endocrinol Metab 296: E384-E393.
18. Wopereis S, Rubingh CM, van Erk MJ, Verheij ER, van Vliet T, et al. (2009) Metabolic profiling of the response to an oral glucose tolerance test detects subtle metabolic changes. PLoS ONE 4: e4525.
19. Mihalik SJ, Goodpaster BH, Kelley DE, Chace DH, Vockley J, et al. (2010) Increased Levels of Plasma Acylcarnitines in Obesity and Type 2 Diabetes and Identification of a Marker of Glucolipotoxicity. Obesity (Silver Spring).
20. Zhao X, Fritsche J, Wang J, Chen J, Rittig K, et al. (2010) Metabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traits. Metabolomics 6:-published online: 07 March 2010.
21. van Doorn M, Vogels J, Tas A, van Hoogdalem EJ, Burggraaf J, et al. (2007) Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers. Br J Clin Pharmacol 63: 562-574.
22. Huo T, Cai S, Lu X, Sha Y, Yu M, et al. (2009) Metabonomic study of biochemical changes in the serum of type 2 diabetes mellitus patients after the treatment of metformin hydrochloride. J Pharm Biomed Anal 49: 976-982.
23. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, et al. (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9: 311-326.
24. Huffman KM, Shah SH, Stevens RD, Bain JR, Muehlbauer M, et al. (2009) Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women. Diabetes Care 32: 1678-1683.
25. Tai ES, Tan ML, Stevens RD, Low YL, Muehlbauer MJ, et al. (2010) Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men. Diabetologia.
26. Han J, Danell RM, Patel JR, Gumerov DR, Scarlett CO, et al. (2008) Towards high-throughput metabolomics using ultrahigh-field Fourier transform ion cyclotron resonance mass spectrometry. Metabolomics 4: 128-140.
27. Ohta D, Kanaya S, Suzuki H (2010) Application of Fourier-transform ion cyclotron resonance mass spectrometry to metabolic profiling and metabolite identification. Curr Opin Biotechnol 21: 35-44.
28. Gougeon RD, Lucio M, Frommberger M, Peyron D, Chassagne D, et al. (2009) The chemodiversity of wines can reveal a metabologeography expression of cooperage oak wood. Proc Natl Acad Sci U S A 106: 9174-9179.
29. Jansson J, Willing B, Lucio M, Fekete A, Dicksved J, et al. (2009) Metabolomics reveals metabolic biomarkers of Crohn's disease. PLoS ONE 4: e6386.
30. Suhre K, Schmitt-Kopplin P (2008) MassTRIX: mass translator into pathways. Nucleic Acids Res 36: W481-W484.
31. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462-1470.
32. Matsuda M (2010) Measuring and estimating insulin resistance in clinical and research settings. Nutr Metab Cardiovasc Dis 20: 79-86.
33. Kernan WN, Inzucchi SE, Viscoli CM, Brass LM, Bravata DM, et al. (2003) Pioglitazone improves insulin sensitivity among nondiabetic patients with a recent transient ischemic attack or ischemic stroke. Stroke 34: 1431-1436.
34. Wold S (1978) Cross-validatory estimation of the number of components in factor and principal components models. Technometrics 20: 397-405.
35. van der Voet H (1994) Comparing the predictive accuracy of models using a simple randomization test. Chemometrics and Intelligent Laboratory Systems 25: 313-323.
36. Das UN (2006) Essential fatty acids: biochemistry, physiology and pathology. Biotechnol J 1: 420-439.
37. Shah SH, Hauser ER, Bain JR, Muehlbauer MJ, Haynes C, et al. (2009) High heritability of metabolomic profiles in families burdened with premature cardiovascular disease. Mol Syst Biol 5: 258.
38. Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B (2009) Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 89: 147-191.
39. Holland WL, Knotts TA, Chavez JA, Wang LP, Hoehn KL, et al. (2007) Lipid mediators of insulin resistance. Nutr Rev 65: S39-S46.
40. Wymann MP, Schneiter R (2008) Lipid signalling in disease. Nat Rev Mol Cell Biol 9: 162-176.
41. Nixon GF (2009) Sphingolipids in inflammation: pathological implications and potential therapeutic targets. Br J Pharmacol 158: 982-993.
42. WHO (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: Report of WHO/IDF consultation, 1-46. WHO Press, Geneva.
43. (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32: 1327-1334.
44. Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, et al. (2007) HMDB: the Human Metabolome Database. Nucleic Acids Res 35: D521-D526.